Established by the combination of international law firm Salans, Canadian law firm Fraser Milner Casgrain (FMC) and international law firm SNR Denton, Dentons is a new global firm driven to provide our clients with a competitive edge in an increasingly complex, interconnected and global marketplace.Dentons connects clients to top tier, innovative and integrated legal talent across Europe, Canada, the UK, the US, the Middle East, Central and East Asia, Asia Pacific and Africa. Our 2,500 lawyers and professionals in 79 locations across 52 countries are dedicated to providing clients with consistent high-quality service wherever they do business. Our offices across the globe serve as portals for our clients to easily access the leading legal talent of Dentons—around the corner or around the world.In today’s rapidly changing business, legal and financial environments, Dentons offers a worldwide knowledge base that provides comprehensive industry sector expertise, local market intelligence and globally informed solutions—invaluable advantages and insights for our clients across the local, regional and international spectrums. With more than 100 lawyers, consultants and policy professionals who have spent their entire professional careers exclusively counseling healthcare life sciences organizations, Dentons is dedicated to providing strategic counsel that focuses on our clients’ success. For more information, visit www.dentons.com.
Jones Day is a global law firm practicing in the major centers of business and finance throughout the world. Ranked among the world’s best and most integrated law firms, and perennially ranked among the best in client service, Jones Day acts as principal outside counsel to, or provides significant legal representation for, more than half of the Fortune Global 500, Fortune 500, and FT Global 500. Jones Day is listed as one of the top litigation departments worldwide for its breadth of knowledge and depth of resources, our practice was named “Litigation Powerhouse” in a 2013 report published by BTI consulting.
Locke Lord LLP is a full-service, international law firm with offices in Atlanta, Austin, Chicago, Dallas, Hong Kong, Houston, London, Los Angeles, New Orleans, New York, Sacramento, San Francisco and Washington, D.C.Our team of approximately 650 attorneys has earned a solid national reputation in complex litigation, regulatory and transactional work. We serve our clients’ interests first, and these clients range from Fortune 500 and middle market public and private companies to start-ups and emerging businesses.
Winston & Strawn LLP is an international law firm with more than 900 attorneys among 15 offices in Beijing, Charlotte, Chicago, Geneva, Hong Kong, Houston, London, Los Angeles, Moscow, New York, Newark, Paris, San Francisco, Shanghai, and Washington, D.C. The exceptional depth and geographic reach of the firm’s resources enable Winston & Strawn to manage virtually every type of business-related legal issue. It serves the needs of enterprises of all types and sizes, in both the private and the public sector.Winston & Strawn understands that clients are looking for value beyond just legal expertise. With this in mind, the firm works hard to understand the level of involvement that its clients want from it. Please visit www.winston.com if you would like more information about Winston & Strawn’s legal services, experience, and the industries it serves.
Cadwalader, Wickersham & Taft LLP, established in 1792, is one of the world’s leading international law firms, with offices in New York, London, Charlotte, Washington, Houston, Beijing, Hong Kong and Brussels. Cadwalader serves a diverse client base, including many of the world’s top financial institutions and corporations, undertaking business in more than 50 countries. The firm offers legal expertise in antitrust, banking, business fraud, corporate finance, corporate governance, energy, environmental, financial restructuring, healthcare, intellectual property, litigation, mergers and acquisitions, private equity, private wealth, real estate, regulation, securitization, structured finance, and tax. More information about Cadwalader can be found at
Nick Repucci is a member of Dentons’ Health Care Practice. He advises biotechnology companies, academic medical centers, community hospitals, physician groups, and other health care organizations on a variety of health research policy matters. He specializes in helping clients ensure compliance with the laws and regulations that govern the conduct of clinical trials, commercial interactions with Health Care Professionals, investigator conflicts of interest, scientific misconduct, prescription drug promotion, and federal grants and contracts administration. Mr. Repucci holds a Master in Public Health from The Dartmouth Institute for Health Policy and Clinical Practice. He can be reached firstname.lastname@example.org.
Jonathan Berman splits his practice between complex commercial litigation and advising on food and drug regulatory issues.Jonathan advises on topics spanning the breadth of the Food, Drug, and Cosmetic Act and other laws administered by the FDA. These matters have involved the regulation of food labeling, food additives, clinical trials, pharmaceutical compounding, “compassionate use” of unapproved drugs, Good Manufacturing Practices, and drug advertising; FOIA requests and the availability of submitted materials; and the regulation of dietary supplements, devices, cosmetics, and radiation emitting products.Jonathan’s litigation practice has emphasized class actions and other complex disputes. Many of Jonathan’s cases have involved health care providers. He has represented, in major matters, hospitals, physician practice groups, a health insurer, manufacturers of pharmaceuticals, and a drug wholesaler.
Scott Jones is a partner with Locke Lord LLP in its Dallas, Texas office. As a member of his firm’s business litigation section, Mr. Jones has tried and defended cases in State and Federal courts, as well as in arbitration. Mr. Jones’s trial experience covers a range of issues with a particular focus on representing pharmaceutical manufacturers in Federal and State False Claims Act and Whistleblower Act lawsuits and investigations. These matters frequently involve allegations of “off label” promotion, the marketing and sale of “misbranded” products, and other state and federal regulatory issues. Mr. Jones’s trial experience also includes general business litigation, products liability litigation, commercial and tort litigation arising out of aviation crashes, and class action defense. Mr. Jones also provides free volunteer legal services to members of the Dallas community.
Erik Snapp is a litigation partner in the Chicago office of Winston & Strawn whose practice focuses on litigation and counseling in high-stakes product liability cases, consumer fraud class actions, internal investigations and SEC investigations. Mr. Snapp currently represents pharmaceutical and medical device companies in state and federal product liability cases, which often involve allegations regarding sales and promotional practices, and advises clients regarding application of the FDA’s off-label promotion regulations. Mr. Snapp has previously defended pharmaceutical manufacturers in False Claims Act litigation involving allegations of off-label promotion, and has defended manufacturers in federal and state criminal and civil investigations focused on sales and contracting practices.
Martin Seidel focuses on complex commercial litigation and arbitration, with an emphasis on multiparty class and derivative suits and corporate control contests. Mr. Seidel is experienced in all aspects of commercial litigation, internal corporate investigations, governmental investigations, and regulatory proceedings. Mr. Seidel has represented key players in the highest profile corporate governance and securities litigations and investigations of the past decade, including Adelphia, Enron, Interstate Bakeries, Hollinger, and HealthSouth.Mr. Seidel received his B.A., magna cum laude, from the University of Wisconsin and his J.D. from Columbia Law School, where he was managing editor of the Columbia Journal of Transnational Law and a Harlan Fiske Stone Scholar. Mr. Seidel has been recognized by New York Super Lawyers, the Legal 500 U.S. Volume III Litigation and Benchmark: Litigation. Mr. Seidel has published articles and spoken on corporate governance, securities litigation, directors’ and officers’ insurance and complex litigation.